Transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses: results from Polish Transcatheter Aortic Valve-in-Valve Implantation (ViV-TAVI) Registry
Bioprosthesis
Transcatheter Aortic Valve Replacement
Treatment Outcome
Aortic Valve
Humans
Poland
Registries
Prosthesis Design
3. Good health
DOI:
10.20452/pamw.16149
Publication Date:
2021-11-30T18:20:44Z
AUTHORS (25)
ABSTRACT
KEy wORds aortic stenosis, transcatheter valve implantation, -in -valveAbsTRACT INTROduCTION Transcatheter -valve implantation (ViV -TAVI) has emerged as an alternative to redo surgery in patients with failed surgical bioprosthesis.ObjECTIvEs We evaluated the safety and efficacy of ViV -TAVI Polish after replacement.PATIENTs ANd mEThOds This was a nationwide multicenter registry procedures.Data were collected using online form, clinical follow -up lasted 1 year.REsuLTs From 2008 2020, 130 procedures performed (1.9% all [TAVI] cases).A considerable increase since 2018 been observed (n = 59, 45% cases).Hancock II, Freestyle, homograft most frequently treated bioprostheses.The self -expanding supra -annular Corevalve / Evolut used 76% cases.In 21% cases, mean postprocedural pressure gradient (PG) exceeded 20 mm Hg.All -cause mortality at year 10.8%.Aortic stenosis associated higher PG than regurgitation or mixed disease (P 0.004).Supra valves lower PGs intra 0.004).Second -generation devices shorter procedure time (120 min vs 135 min, P 0.04), less frequent need for additional TAVI (2% 10%, -year cardiovascular (95% 82.8%, 0.03) first valves.CONCLusIONs treatment bioprostheses is increasingly common, best hemodynamic effect shown valves.The introduction second improved procedural outcomes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....